Trials / Completed
CompletedNCT03988699
Novel Tinnitus Implant System for the Treatment of Chronic Severe Tinnitus
Novel Tinnitus Implant System for the Treatment of Chronic Severe Tinnitus: An Early Feasibility Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Matthew L. Carlson, M.D. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Researchers are gathering information on the safety and effectiveness of a novel device called the Tinnitus Implant System for the treatment of tinnitus.
Detailed description
This study requires one year of participation with at least 21 visits to Mayo Clinic in Rochester MN for device programming and audiometric testing. The device is implanted during an outpatient surgery. Participants may keep the study device after participation is complete.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tinnitus Implant System | Device will deliver stimulation below hearing thresholds continuously or intermittently. |
Timeline
- Start date
- 2021-08-23
- Primary completion
- 2024-09-10
- Completion
- 2024-09-10
- First posted
- 2019-06-17
- Last updated
- 2026-02-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03988699. Inclusion in this directory is not an endorsement.